JP2025506775A - アネキシンａ１由来のポリペプチド類似体 - Google Patents

アネキシンａ１由来のポリペプチド類似体 Download PDF

Info

Publication number
JP2025506775A
JP2025506775A JP2024549631A JP2024549631A JP2025506775A JP 2025506775 A JP2025506775 A JP 2025506775A JP 2024549631 A JP2024549631 A JP 2024549631A JP 2024549631 A JP2024549631 A JP 2024549631A JP 2025506775 A JP2025506775 A JP 2025506775A
Authority
JP
Japan
Prior art keywords
lys
polypeptide
seq
amino acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549631A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506775A5 (https=
Inventor
エンゲルブレヒト ノルトキルト ジョナサン，トーマス
Original Assignee
リゾサー ファーマ エー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リゾサー ファーマ エー／エス filed Critical リゾサー ファーマ エー／エス
Publication of JP2025506775A publication Critical patent/JP2025506775A/ja
Publication of JP2025506775A5 publication Critical patent/JP2025506775A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024549631A 2022-02-23 2023-02-23 アネキシンａ１由来のポリペプチド類似体 Pending JP2025506775A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158253 2022-02-23
EP22158253.9 2022-02-23
PCT/EP2023/054519 WO2023161323A1 (en) 2022-02-23 2023-02-23 Annexin a1-derived polypeptide analogues

Publications (2)

Publication Number Publication Date
JP2025506775A true JP2025506775A (ja) 2025-03-13
JP2025506775A5 JP2025506775A5 (https=) 2026-03-04

Family

ID=80461005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549631A Pending JP2025506775A (ja) 2022-02-23 2023-02-23 アネキシンａ１由来のポリペプチド類似体

Country Status (7)

Country Link
US (1) US20250388632A1 (https=)
EP (1) EP4482853A1 (https=)
JP (1) JP2025506775A (https=)
CN (1) CN118891273A (https=)
AU (1) AU2023226134A1 (https=)
CA (1) CA3249181A1 (https=)
WO (1) WO2023161323A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025083393A1 (en) * 2023-10-16 2025-04-24 Therakind Limited Antimicrobial use of peptides derived from annexin a1

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002364607A1 (en) * 2001-12-28 2003-07-24 The Burnham Institute Novel ligand involved in the transmigration of leukocytes .
FR2856069A1 (fr) * 2003-06-10 2004-12-17 Bionexis Molecules de ciblage et de liberation de composes therapeutiques et leur utilisation
US9102753B2 (en) 2011-06-15 2015-08-11 Ugp Therapeutics, Inc. Anti-inflammatory pharmaceutical products
KR20150029457A (ko) * 2013-09-10 2015-03-18 삼성전자주식회사 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도
JP2017513875A (ja) 2014-04-22 2017-06-01 ティーエックスピー ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 分枝状アミノ酸プローブを有するペプチド類似体

Also Published As

Publication number Publication date
AU2023226134A1 (en) 2024-08-01
EP4482853A1 (en) 2025-01-01
US20250388632A1 (en) 2025-12-25
WO2023161323A1 (en) 2023-08-31
CN118891273A (zh) 2024-11-01
CA3249181A1 (en) 2023-08-31

Similar Documents

Publication Publication Date Title
US20230295255A1 (en) Annexin a1-derived polypeptide analogues
US9951116B2 (en) Alpha- and gamma-MSH analogues
JPH08510205A (ja) Ｙｙペプチドのアナログとその用途
CZ183396A3 (en) Growth hormone release stimulating compounds
US20180170991A1 (en) Long-acting adrenomedullin derivatives
CZ100693A3 (en) Non-peptidic antagonists of bembesin
JP2007526240A (ja) ブラジキニンｂ１受容体の拮抗薬
CN117959459A (zh) 肿瘤微环境激活的药物偶联物及抗体药物偶联物
WO2015162483A1 (en) Alpha- and gamma-msh analogues
CN119431514A (zh) 一种gcgr、gipr和glp-1r三重靶向激动作用的多肽衍生物
US20150376254A1 (en) Gamma-msh analogues
JP2025506775A (ja) アネキシンａ１由来のポリペプチド類似体
WO2021013131A1 (en) Hemoglobin-based therapeutic agents
WO2017068020A1 (en) W-peptide analog
RS49733B (sr) Soli bpc peptida sa organo- zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena
JP2001226284A (ja) 神経突起誘発剤
WO2025130991A1 (zh) 肿瘤微环境激活的药物偶联物及抗体药物偶联物
CN116390938A (zh) 毒蜥外泌肽-4类似物
US6949513B2 (en) Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer
KR20220102128A (ko) 신규 그렐린 유사체 및 이를 함유하는 아밀로이드 베타 응집 관련 질환의 예방 또는 치료용 약학 조성물
WO2023088236A1 (zh) Mt1-mmp的双环肽配体及其缀合物
WO2021117754A1 (ja) Ｄｎａ損傷の抑制又は修復剤
WO2008050161A2 (en) Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
JP2003073301A (ja) 神経毒性低下剤
BR112015008767B1 (pt) Peptídeo, composição farmacêutica e uso do peptídeo

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260224